TRAVERE THERAPEUTICS

Pharmaceuticals

3611 Valley Centre Drive Suite 300 San Diego CA 92130, San Diego, CA  ·  CHRISTOPHER PORTER

Filings
43
Clients
1
Total Income
Years Active
2016–2026

Filings

Year Client Period Income Expenses Doc
2026 TRAVERE THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$200,000
2025 TRAVERE THERAPEUTICS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$260,000
2025 TRAVERE THERAPEUTICS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$110,000
2025 TRAVERE THERAPEUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$200,000
2025 TRAVERE THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$160,000
2024 TRAVERE THERAPEUTICS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$100,000
2024 TRAVERE THERAPEUTICS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$120,000
2024 TRAVERE THERAPEUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$140,000
2024 TRAVERE THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$170,000
2023 TRAVERE THERAPEUTICS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$105,000
Page 1 of 5  ·  43 filings Next

Clients Represented

ClientFilingsTotal Income
TRAVERE THERAPEUTICS 43

Lobbyists

NameDisclosed Prior Position
ROSE GALLAGHER
CHRISTOPHER PORTER